Xiaohu Zhang
Shanghai University(CN)National Institutes of Health(US)Chinese University of Hong Kong(HK)Huazhong Agricultural University(CN)Sichuan University(CN)Soochow University(CN)West China Second University Hospital of Sichuan University(CN)National Center for Advancing Translational Sciences(US)University of Science and Technology Beijing(CN)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Adenosine and Purinergic Signaling, interferon and immune responses, Hedgehog Signaling Pathway Studies, Receptor Mechanisms and Signaling
Most-Cited Works
- → RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription(2016)295 cited
- → Early glycolytic reprogramming controls microglial inflammatory activation(2021)241 cited
- → Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature(2009)220 cited
- → Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress(2021)176 cited
- → A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm(2016)153 cited
- → Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis(2019)113 cited